Status:

COMPLETED

Pilot Study of Genotypic Analysis

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

Influenza

Eligibility:

All Genders

50+ years

Brief Summary

Influenza (the flu) is a leading cause of respiratory (breathing) illness that leads to sickness and death during the winter months. A better understanding of why certain people get the flu or get sic...

Detailed Description

Influenza is a leading vaccine preventable cause of respiratory illness that leads to substantial morbidity and mortality during the winter months. It is defined by a rapid-onset systemic illness, wit...

Eligibility Criteria

Inclusion

  • Male or female, aged greater than or equal to 50 years
  • For SUBJECTS: Enrolled in a Vaccine Treatment and Evaluation Unit (VTEU)-funded surveillance study conducted during the 2006 - 2007 influenza season \[Division of Microbiology and Infectious Diseases (DMID) study 06-0051\]
  • Residents of surveillance areas
  • For SUBJECTS: Persons who have been hospitalized with respiratory symptoms or fever and polymerase chain reaction (PCR) or culture confirmed influenza virus OR
  • For CONTROLS: Living with or in frequent contact with SUBJECT
  • For CONTROLS: Genetically unrelated to the SUBJECT
  • Willing and able to provide signature documentation of informed consent or parental permission

Exclusion

  • For SUBJECTS: Not enrolled in a Vanderbilt led respiratory disease surveillance study \[Division of Microbiology and Infectious Diseases (DMID) study 06-0051\]
  • For SUBJECTS: Receipt of blood products in the past 6 months
  • Anything in the opinion of the Investigator that would prevent the subject from successfully participating in this study
  • For CONTROLS: Influenza infection during the 2006-2007 flu season

Key Trial Info

Start Date :

May 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2008

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT00421837

Start Date

May 1 2007

End Date

December 1 2008

Last Update

August 16 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center

Nashville, Tennessee, United States, 37232-2573